ProCE Banner Activity

CE

Frontiers in RSV Prevention for Older Adults: Developments, Recommendations, and the Pharmacist’s Role

Multimedia

Join this on-demand webcast to get expert pharmacists’ recommendations on recently approved RSV vaccines for adults aged 60 years and older. Faculty provide key insights for strategies to incorporate RSV vaccination in your practice, methods of identifying patients who would benefit from RSV prevention, and tools to provide evidence-based and up-to-date education.

Pharmacists: 1.00 contact hour (0.1 CEUs)

Released: November 22, 2023

Expiration: November 22, 2024

Share

Faculty

Mary Barna Bridgeman

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP

Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital New Brunswick
New Brunswick, New Jersey

Christina M. Madison

Christina M. Madison, PharmD, FCCP, BCACP, AAHIVP

Clinical Pharmacist
Founder and CEO, The Public Health Pharmacist, PLLC
Adjunct Associate Professor of Pharmacy Practice
Roseman University of Health Sciences
College of Pharmacy
Henderson, Nevada

Provided by

Provided by ProCE, LLC, in partnership with Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer, Inc.

Partners

Clinical Care Options, LLC

ProCE Banner

Target Audience

The target audience for this program is pharmacists, including community, ambulatory care, health-system, and infectious diseases pharmacists, as well as other pharmacy professionals involved in the care of adults eligible for RSV immunization.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with Vaccination

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the burden of RSV infections in older adults, including disease manifestations and risk factors for severe outcomes

  • Compare available and emerging RSV vaccines for older adults, including mechanisms of action and safety and efficacy data

  • Optimize uptake of RSV vaccination in older adults using evidence-based shared clinical decision-making principles

Disclosure

ProCE, LLC requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to ProCE policy. ProCE is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP

Clinical Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Internal Medicine Pharmacist
Robert Wood Johnson University Hospital New Brunswick
New Brunswick, New Jersey

Mary Barna Bridgeman, PharmD, BCPS, BCGP, FASCP, FCCP, FNAP, has no relevant financial relationships to disclose.

Christina M. Madison, PharmD, FCCP, BCACP, AAHIVP

Clinical Pharmacist
Founder and CEO, The Public Health Pharmacist, PLLC
Adjunct Associate Professor of Pharmacy Practice
Roseman University of Health Sciences
College of Pharmacy
Henderson, Nevada

Christina M. Madison, PharmD, FCCP, AAHIVP: consultant/advisor/speaker: Janssen Therapeutics, Pfizer, ViiV.

The planners and content peer reviewers from ProCE, LLC and Clinical Care Options, LLC do not have any relevant financial relationships to disclose.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1 hours. To successfully complete this activity and receive credit, learners must follow these steps during the period from November 22, 2023, through November 22, 2024:

  1. Login or Sign Up for an account by clicking at the top of this page.
  2. Read the target audience, learning objectives, and faculty disclosures.
  3. View and study the content in its entirety.
  4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65 and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the confirmation page. Records of all CME/CE activities completed can be found on the "My Certificates" page. There are no costs/fees for this activity.

Format

This program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Accreditation

Pharmacist

This activity is jointly provided by ProCE, LLC and Clinical Care Options, LLC. ProCE, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-23-033-H06-P has been assigned to this home study application-based activity. This activity is approved for 1.0 contact hour (0.10 CEU) in states that recognize ACPE providers. The activity is provided at no cost to participants. Completion of the evaluation and the post-test with a score of 65 or higher are required to receive CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.